Q-Restrain IV Therapy
A cancer diagnosis — or a chronic infection that never fully clears — leaves you searching for every precise, evidence-based option available. At SeeBeyond Medicine in Scarsdale, NY and Greenwich, CT, Q-Restrain (Supportive Oligonucleotide Technique) uses custom-designed oligonucleotides, built from your own blood sample, to target the genetic machinery of cancer cells, viruses, and chronic infections.
Formerly known as SOT therapy, Q-Restrain is a personalized, IV-administered therapy that stays active for months after a single infusion — engaging your body's defenses with genetic precision rather than broad, non-specific treatment.
Schedule your Q-Restrain consultation at SeeBeyond Medicine.
Credentials
Why SeeBeyond Medicine
Dr. Hyun Joon Lee, triple board-certified in Family Medicine, Integrative Holistic Medicine, and Obesity Medicine, founded SeeBeyond Medicine in 2006. With over 20,000 patients treated and integrative oncology as a core specialization, SeeBeyond Medicine coordinates every Q-Restrain protocol with your conventional oncology or infectious-disease team for safe, complementary care.
Visit our Scarsdale, NY office or Greenwich, CT office for Q-Restrain therapy.
About This Service
What Is Q-Restrain IV Therapy?
Q-Restrain — Supportive Oligonucleotide Technique, formerly called SOT therapy — uses short strands of RNA or DNA (oligonucleotides) designed to bind the messenger RNA of disease-causing cells. Developed from your own blood sample, these oligonucleotides disrupt the replication and survival mechanisms of the target with exceptional specificity.
Each Q-Restrain oligonucleotide is engineered around gene sequences identified through advanced blood analysis, then designed in silico and validated in vitro before administration. Because the therapy is derived from your own biological sample, it is autologous — minimizing the risk of adverse reactions.
After a 90-minute intravenous infusion, Q-Restrain remains therapeutically active for up to six months, providing continuous, around-the-clock activity against its target. SeeBeyond Medicine administers Q-Restrain as part of individualized protocols, coordinated with your conventional oncology or infectious-disease care.
Conditions Treated
Cancer — Solid Tumors and Blood Cancers
Q-Restrain targets genes critical to cancer-cell survival, helping induce apoptosis in solid tumors and hematologic cancers. SeeBeyond Medicine uses it to complement conventional oncology without harmful interactions.
Benefits
Precision Genetic Targeting
Precision Genetic Targeting
Q-Restrain binds the specific gene sequences identified in your blood analysis, acting on disease-causing cells with a level of specificity that broad therapies cannot match. SeeBeyond Medicine designs each oligonucleotide for your individual disease profile.
Autologous, Personalized Design
Because Q-Restrain is derived from your own biological sample, it is tailored to you and designed to minimize adverse reactions. Every batch is validated in the laboratory before it reaches you.
Continuous 24/7 Activity for Months
A single 90-minute infusion remains therapeutically active for up to six months, delivering continuous, around-the-clock action against its target between treatments.
What to Expect
Your Journey
1. Diagnostic Blood Analysis
Your Q-Restrain protocol begins with RGCC laboratory testing, which uses advanced circulating-tumor-cell (CTC) and blood analysis to identify the disease-specific gene sequences to target.
2. Therapy Design and Validation
Custom oligonucleotides are designed in silico against your identified sequences and validated in vitro for maximum specificity before they are prepared for infusion.
3. IV Infusion Administration
Q-Restrain is administered as a 90-minute intravenous infusion in our comfortable suite at our Scarsdale or Greenwich office. A single infusion provides continuous therapeutic activity for months.
4. Monitoring and Treatment Spacing
SeeBeyond Medicine monitors your response and schedules follow-up treatments within established limits — up to four per year for cancer, spaced at least three months apart, and up to nine per year for viral or Lyme protocols, spaced at least 21 days apart.
What Our Patients Say
Patient Experiences
Real stories from patients who found answers.
Patients across Westchester and Fairfield County come to SeeBeyond Medicine for Q-Restrain when conventional options have stalled. They value a precise, personalized therapy — designed from their own blood — that works quietly in the background for months, alongside the rest of their care.
Q-Restrain is not currently FDA-approved and is considered an investigational therapy. It is offered as part of our integrative approach and is not intended to replace conventional cancer treatment. SeeBeyond Medicine evaluates each patient individually and treats within established clinical guidelines.
Frequently Asked Questions
Common Questions
What is Q-Restrain, and how is it related to SOT therapy?
Q-Restrain is SeeBeyond Medicine's name for Supportive Oligonucleotide Technique, formerly called SOT therapy. It uses custom oligonucleotides — short strands of RNA or DNA — designed from your own blood to target the genetic machinery of cancer cells, viruses, and chronic infections.
What conditions can Q-Restrain target?
Q-Restrain can be designed against solid tumors and blood cancers, chronic bacterial infections such as Lyme disease, Babesia, and Bartonella, and chronic viral infections including EBV, CMV, HSV, hepatitis B and C, HPV, Coxsackie, and HTLV-1.
How long does Q-Restrain stay active?
A single 90-minute IV infusion remains therapeutically active for up to six months, providing continuous activity against its target between treatments.
Is Q-Restrain a replacement for conventional cancer treatment?
No. Q-Restrain is offered as part of an integrative approach and is designed to complement conventional care. It is not FDA-approved, is considered investigational, and is not intended to replace chemotherapy, radiation, or other standard treatment.
Who is not a candidate for Q-Restrain?
Q-Restrain is generally avoided during pregnancy or breastfeeding, after a recent blood transfusion, and shortly after chemotherapy or radiation, with waiting periods applied. Certain treatments — including radioactive seed therapy — are permanent exclusions. SeeBeyond Medicine screens for these before treatment.
Related Services
Related Services
- High-Dose Vitamin C IV for integrative oncology support
- Mistletoe Therapy for immune-stimulating integrative cancer care
- Artesunate Therapy for artemisinin-based integrative oncology
Take the First Step
Take the Next Step
Even if conventional options feel exhausted, SeeBeyond Medicine's Q-Restrain therapy offers a precise, physician-supervised approach that targets your disease at its genetic foundation — designed uniquely from your own blood.
Schedule a Free Consultation for Q-Restrain therapy in Scarsdale or Greenwich